Filing Details
- Accession Number:
- 0000930413-11-007438
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-11-17 11:49:30
- Reporting Period:
- 2011-11-16
- Filing Date:
- 2011-11-17
- Accepted Time:
- 2011-11-17 11:49:30
- Original Submission Date:
- 2011-11-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 901503 | W Barry Weiner | C/O Enzo Biochem, Inc. 527 Madison Avenue New York, NY 10022 | Pres, Cfo, Princ Ao And Treasr | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 2,000 | $2.25 | 1,294,206 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 2,182 | $2.27 | 1,296,388 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 6,000 | $2.28 | 1,302,388 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 3,000 | $2.29 | 1,305,388 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 4,818 | $2.30 | 1,310,206 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 2,000 | $2.32 | 1,312,206 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This amendment is being filed solely to correct a typographical error in box 4 of Table I to correctly indicate that the securities were acquired and not disposed of.
- Includes (i) 239,000 shares of Common Stock issuable upon the exercise of options which are exercisable within 60 days from the date hereof, (ii) 3,638 shares of Common Stock held in the name of the Reporting Person as custodian for certain of his children and (iii) 12,510 shares of Common Stock held in the Company's 401(k) plan.
Billionaire Hedge Funds
